bioAffinity Technologies (BIAF) EPS (Weighted Average and Diluted): 2022-2025
Historic EPS (Weighted Average and Diluted) for bioAffinity Technologies (BIAF) over the last 4 years, with Sep 2025 value amounting to -$4.74.
- bioAffinity Technologies' EPS (Weighted Average and Diluted) rose 2.07% to -$4.74 in Q3 2025 from the same period last year, while for Sep 2025 it was $10.40, marking a year-over-year increase of 289.44%. This contributed to the annual value of -$0.75 for FY2024, which is 17.58% up from last year.
- According to the latest figures from Q3 2025, bioAffinity Technologies' EPS (Weighted Average and Diluted) is -$4.74, which was down 2,688.24% from -$0.17 recorded in Q2 2025.
- bioAffinity Technologies' 5-year EPS (Weighted Average and Diluted) high stood at $15.47 for Q4 2024, and its period low was -$4.84 during Q3 2024.
- Its 3-year average for EPS (Weighted Average and Diluted) is $0.39, with a median of -$0.20 in 2024.
- Examining YoY changes over the last 5 years, bioAffinity Technologies' EPS (Weighted Average and Diluted) showed a top increase of 6,050.00% in 2024 and a maximum decrease of 1,761.54% in 2024.
- bioAffinity Technologies' EPS (Weighted Average and Diluted) (Quarterly) stood at $0.22 in 2022, then crashed by 218.18% to -$0.26 in 2023, then surged by 6,050.00% to $15.47 in 2024, then rose by 2.07% to -$4.74 in 2025.
- Its EPS (Weighted Average and Diluted) was -$4.74 in Q3 2025, compared to -$0.17 in Q2 2025 and -$0.16 in Q1 2025.